Joann Blessing-Moore is a Rheumatology/Immunology physician. OpenAlex indexes 67 publications with 12,992 citations (h-index 40). By OpenAlex citation count, this profile ranks in the top 5% of Allergy & Immunology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
723 Emerson St
Palo Alto, CA 943012411
Telephone
650-688-8480Registry record last updated 15 Jan 2015.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- LEO Pharma Inc.Program year20212 payments
- ALK-Abello, IncProgram year20213 payments
- Grifols Shared Services North America, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%Corticosteroid45.7%Fluticasone Propionate36%Symbicort32%Flovent Hfa14%Breo Ellipta12%Qvar Redihaler8%Part D<11 patientsHistamine-1 Receptor Antagonist26.3%Azelastine Hcl80%Dymista20%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure
The Journal of Allergy and Clinical Immunology In Practice
2020 - Work Group Report: Perspectives in Diagnosis and Management of Exercise-Induced Bronchoconstriction in Athletes
The Journal of Allergy and Clinical Immunology In Practice
2020
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”